Cardiovascular effects of testosterone

Current Sexual Health Reports

Volumn 5, Issue 4, 2008, Pages 187-189

  Jackson, Graham ^a  

^a LONDON BRIDGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TESTOSTERONE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE MODEL; DRUG MECHANISM; ENDOTHELIUM; FOLLOW UP; HEART MUSCLE ISCHEMIA; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OBESITY; REVIEW; RISK FACTOR; STABLE ANGINA PECTORIS;

EID: 60149104829     PISSN: 15483584     EISSN: 15483592     Source Type: Journal    
DOI: 10.1007/s11930-008-0033-6     Document Type: Review

References (26)

1. Stevenson JC: Cardiovascular disease in women. Menopause Int 2008, 14:5.
2. Jackson G. Gender differences in cardiovascular disease prevention. Menopause Int 2008, 14:13-17.
3. Basaria S, Dobs AS: Testosterone making an entry into the cardiometabolic world. Circulation 2007, 116:2658-2661.
4. AlexandersTn P, Christiansen C: The aging male: testosterone deficiency and testosterone replacement. An update. Atherosclerosis 2004, 173:157-169.
5. Allan CA, Strauss BJG, McLachlan RI: Body composition, metabolic syndrome and testosterone in ageing men. Int J Impot Res 2007, 191:448-457.
6. Kapelman PG: Obesity as a medical problem. Nature 2000, 404:635-643.
7. Jackson G: The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep 2007, 8:463-466.
8. Makhsida N, Shah J, Yan G, et al.: Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol 2005, 174:827-834.
9. Shabsigh R, Arver S, Channer KD, et al.: The trial of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 2008, 62:672-674.
10. Kirby M: A new look at the hormonal and metabolic changes in the ageing male. Int J Clin Pract 2008, 62:672-674.
11. Grundy SM: Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab 2004, 89:2595-2600.
12. Cannon CP, Steinberg BA, Murphy SA, et al.: Meta-analysis of cardiovascular outcome trials comparing intensive versus moderate statin therapy. J Am Coll Cardio 2006, 48:438-445.
13. Bagatell CJ, Knopp RH, Vale WW, et al.: Physiologic testosterone levels in normal men suppresses high-density lipoprotein cholesterol levels. Ann Intern Med 1992, 116:967-973.
14. Snyder PJ, Peachey H, Berlin JA, et al.: Effect of transdermal testosterone on serum lipid and apolipoprotein levels in men more than 65 years of age. Am J Med 2001, 111:255-260.
15. Tenover JS: Efforts of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992, 25:1092-1098.
16. Buvat J, Shabsigh R, Guay A, et al.: Hormone, metabolism, aging and men's health. In Standard Practice in Sexual Medicine. Edited by Porst H, Buvat J. Oxford, UK: Blackwell; 2006:225-286
17. Channer KS, Jones TH: Cardiovascular effects of testosterone: implications of the "male menopause"? Heart 2003, 89:121-122.
18. English KM, Jones RD, Jones TG, et al.: Gender differences in the vasodilator effects of different steroid hormones in rat pulmonary and cardiovascular arteries. Horm Metab Res 2001, 33:645-652.
19. Jones RD, Pugh PJ, English KM, et al.: Isolated arteries from testicular feminised mice have maintained dilator response to testosterone but reduced vascular reactivity to acetylcholine. Br J Pharmacol 2001, 135:P129.
20. Rosano GMC, Leonardo F, Pagnotta P, et al.: Acute antiischemic effect of testosterone in men with coronary artery disease. Am J Cardiol 1999, 83:437-439.
21. English KM, Steeds RP, Diver MJ, et al.: Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. Circulation 2000, 102:1906-1911.
22. Muller M, Van den Beld AW, Bots ML, et al.: Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004, 109:2074-2079.
23. Khaw K-T, Dowsett M, Folkerd E, et al.: Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men. Circulation 2007, 116:2694-2701.
24. Liu PY, Death AK, Handelsman DJ: Androgens and cardiovascular disease. Endocr Rev 2003, 24:313-340.
25. Laughlin GA, Barrett-Connor E, Bergstrom J: Low testosterone and mortality in older men. J Clin Endocrinol Metab 2008, 93:68-75.
26. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR: Low serum testosterone and mortality in male veterans. Arch Intern Med 2006, 166:1660-1665.